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Abstract
Semenogelin I (SEMG1) is found in human semen coagulum and on the surface of spermatozoa bound to EPPIN.
The physiological significance of the SEMG1/EPPIN interaction on the surface of spermatozoa is its capacity to
modulate sperm progressive motility. The present study investigates the hypothesis that the interacting surface of
SEMG1 and EPPIN co-evolved within the Hominoidea time scale, as a result of adaptive pressures applied by their
roles in sperm protection and reproductive fitness. Our results indicate that some amino acid residues of SEMG1 and
EPPIN possess a remarkable deficiency of variation among hominoid primates. We observe a distinct residue
change unique to humans within the EPPIN sequence containing a SEMG1 interacting surface, namely His92. In
addition, Bayes Empirical Bayes analysis for positive selection indicates that the SEMG1 Cys239 residue underwent
positive selection in humans, probably as a consequence of its role in increasing the binding affinity of these
interacting proteins. We confirm the critical role of Cys239 residue for SEMG1 binding to EPPIN and inhibition of
sperm motility by showing that recombinant SEMG1 mutants in which Cys239 residue was changed to glycine,
aspartic acid, histidine, serine or arginine have reduced capacity to interact to EPPIN and to inhibit human sperm
motility in vitro. In conclusion, our results indicate that EPPIN and SEMG1 rapidly co-evolved in primates due to their
critical role in the modulation of sperm motility in the semen coagulum, providing unique insights into the molecular
co-evolution of sperm surface interacting proteins.
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Introduction
In primates, semen is a complex biological fluid containing
spermatozoa bathed by the seminal plasma, which nurtures
spermatozoa while providing the appropriate conditions for the
last steps of post-testicular sperm maturation, and protecting
them from pathogenic threats during their journey towards
fertilization in the female reproductive tract [1]. The seminal
vesicle-secreted protein semenogelin I (SEMG1) is the major
component of the seminal plasma [2]. Immediately after
ejaculation, human semen undergoes a coagulation process
forming a gelatinous mass that contains SEMG1 as its
structural element [3]. SEMG1 is found in the semen coagulum
and on the surface of spermatozoa bound to EPPIN, a member
of the whey-acidic protein (WAP)-type four-disulfide core
(WFDC) family [4,5]. After ejaculation, the hydrolysis of SEMG1
by activated prostate-specific antigen (PSA), a serine protease,
results in the liquefaction of the semen coagulum allowing
spermatozoa to acquire progressive motility [2,6].
The physiological significance of the SEMG1/EPPIN
interaction on the surface of spermatozoa is its capacity to
modulate sperm progressive motility upon ejaculation in a finely
time-regulated manner [5,7]. In parallel, EPPIN inhibits the
digestion of SEMG1 by PSA, which results in the modulation of
semen liquefaction, further prolonging the inhibitory effects of
SEMG1 on sperm motility [8]. This effect is thought to be
important for reproduction because it allows spermatozoa to
achieve their full fertilizing capacity at the appropriate moment.
Men whose semen coagulum fails to liquefy spontaneously
have spermatozoa with poor motility and are infertile [9].
Additionally, EPPIN and some SEMG1-proteolytic peptides
derived by PSA cleavage have strong antibacterial activity in
vitro and may protect the integrity of spermatozoa against
microorganisms present in the vaginal environment [10-13].
The critical roles of SEMG1 and EPPIN in reproduction are
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highlighted by the fact that male monkeys immunized with
human recombinant EPPIN that developed high titers of anti-
EPPIN antibodies lacked semen coagulum upon ejaculation
and became reversibly infertile [14]. Subsequent studies
demonstrated that anti-EPPIN antibodies isolated from
immunized monkeys blocked the SEMG1 binding site on
EPPIN’s C-terminal region and mimicked SEMG1 binding by
inhibiting progressive motility of human spermatozoa [15,16].
Because of these observations, the SEMG1 binding interface
on EPPIN has been acknowledged as a potential target for
male contraception [5].
The WFDC locus on human chromosome 20q13, containing
the SEMG1 (in the centromeric cluster) and EPPIN (in the
telomeric cluster) genes [17,18], has undergone strong
adaptive pressure [19] and the SEMG1 gene in particular has
undergone rapid adaptive evolution [18-21], suggesting positive
selection driven by their functions in natural immunity and
reproductive success [19]. Genes for serine protease inhibitors
within the WFDC locus may have been progenitors to the
SEMG genes [17,22]. In previous studies on the interaction of
SEMG1 with EPPIN on the sperm surface, we demonstrated
that EPPIN’s Cys102, Tyr107, and Phe117 were necessary for
SEMG1 binding [23] and that SEMG1’s Cys239 was required
for binding to EPPIN with subsequent inhibition of sperm
motility [24,25]. The SEMG1 amino acid residue Cys239 has
been shown to be under positive selection [18]. Consequently
we have asked whether EPPIN and SEMG1 have undergone
co-adaptive evolution into a receptor ligand relationship that
provides protection for spermatozoa and regulates the
acquisition of progressive sperm motility prior to capacitation.
Here we demonstrate that the Hominoidea underwent a distinct
change in specific EPPIN and SEMG1 amino acid residues that
appears to be a directional selection throughout the Hominidae
(human and great apes) and Hylobatidae (gibbon) Families,
resulting in a high affinity binding site between EPPIN and
SEMG1 and a functional gain regarding its ability to inhibit
sperm motility.
Results
Phylogenetic Analysis of EPPIN and SEMG1
The Catarrhini (old world monkeys, great apes, gibbons, and
humans) emerged 43.5 million years ago (MYA) from a
common ancestor and subsequently diverged into the
Hominoidea and Cercopithecoidea 31.6 MYA [26]. The
Homininae emerged 8.3 MYA and underwent rapid speciation
into three genera (Gorilla, Pan, Homo); the Gorilla branching
rapidly away from the Homo-Pan genera [26]. We examined
the molecular phylogeny of EPPIN and SEMG1 within the
Hominoidea and of Macaca mulatta and Papio anubis within
the Cercopithecoidea and found 2.2 more substitutions per site
in the SEMG1 lineage (Figure 1A, B). The Maximum Likelihood
method gave the same tree for EPPIN (Figure 1A) as all other
methods and conformed to the expected evolutionary tree for
primates [26]. However, using the same methodology, all the
methods gave an unexpected tree for the SEMG1 sequence
(Figure 1B) showing the Gorilla branching from the common
ancestor of the Cercopithecoidea rather than the common
ancestor of the Homininae. A test of the homogeneity of
substitution patterns between sequences revealed that the
Gorilla EPPIN sequence exhibits heterogeneity with Homo,
Pan and Pongo (Table 1, asterisks in row 1 vs. column 3, row 2
vs. column 3, and row 3 vs. column 4), whereas the Gorilla
SEMG1 sequence exhibits heterogeneity with Macaca mulatta
(Table 2, asterisks in row 3 vs. column 6) and, although not
statistically significant, a trend towards heterogeneity with
Homo sapiens (Table 2, trend symbol in row 1 vs. column 3,
row 3 vs. column 6). Although there was an overabundance of
non-synonymous substitutions in several codons in each
lineage, only SEMG1 showed positively selected codons that
were statistically significant (Table S1 and Table S2).
We found no evidence of positive selection in any site within
the primate phylogenetic tree of EPPIN (Table S1). On the
other hand, detailed examination of the full-length EPPIN
sequence revealed that when the Hominoidea and
Cercopithecoidea Superfamilies emerged from the Catarrhini
31.6 MYA the Hominoidea underwent a distinct change in
seven amino acid residues (Lys35, Lys50, Asp51, Gln55,
Lys81, Tyr89, Leu91, Met104, and Lys120) that appears to be
a directional selection throughout the Hominidae and
Hylobatidae Families (Table 3), separating them from the
Papionini. An examination of the EPPIN sequence within the
SEMG1 binding site in the Kunitz domain [23] revealed only
two residue changes that were different between Homo and all
the other Hominoidea, namely His92 and Asp99. Only His92
projects into the binding pocket [23] and would represent a
significant change from Arg92 in charge and size.
Analysis of the SEMG1 sequence in fragment 74-8 (R165-
Q247; Figure 2), a fragment still retaining EPPIN binding and
sperm motility inhibitory activities (see below), revealed that the
Hominoidea underwent a distinct change in four amino acid
residues (Trp167, His169, Ser193, and Gln215), which might
be indicative of a directional selection in Hominidae (Table 4).
Additionally, Bayes Empirical Bayes (BEB) analysis [27]
revealed eleven positively selected codons in this SEMG1
sequence (Table 4; Table S2); only two (Trp167, His169) were
throughout the Hominoidea. Although there were no amino acid
residue differences between Homo sapiens and all other
Hominoidea, residues Asp225 and Leu234 in the Gorilla were
distinct from other Hominidae and Hylobatidae residues,
Glu225 and Val234 respectively, but identical to Macaca
mulatta and Papio anubis residues (Table 4). Residue His239
was unique in the Gorilla SEMG1 in comparison to SEMG1
from other Hominidae and Hylobatidae (Cys239), as well as
Macaca mulatta and Papio anubis (Arg239). Residue Cys239
and His169 were reported previously to be sites under positive
selection [18] and our BEB analysis confirmed that the Cys239
codon underwent positive selection (Table 4; Table S2). Homo
sapiens Cys239, which is necessary for SEMG1 binding to
EPPIN [24,25], underwent a distinct change when the
Hominidae and Hylobatidae Families separated from the
Cercopithecidae (R239C). Consequently, based on our
phylogenetic analysis, it is likely that the positive selection of
eleven of SEMG1’s codons within the WFDC locus of the
Hominoidea and the co-evolution of EPPIN’s His92 resulted in
the high affinity binding of SEMG1 to EPPIN in humans.
Evolution of SEMG1/EPPIN Binding on Spermatozoa
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Binding of SEMG1 fragments and Cys239 mutants to
EPPIN
As we reported previously [23], the binding of human
recombinant SEMG1214-42 fragment to EPPIN was time-
dependent (Figure S1) and saturable (Figure 3A). Experiments
performed using increasing concentrations of SEMG1214-42
(0.04 - 7.5 µM) in the presence of a constant concentration of
EPPIN indicated a concentration-dependent increase in the
signal up to 300 nM SEMG1214-42 (Figure 3A and Figure S1). At
higher SEMG1214-42 concentrations, we observed a progressive
drop in the signal due to oversaturation of Ni-NTA-chelate
donor beads with SEMG1214-42 (the hook effect [28], Figure S1).
In order to determine the smallest region within SEMG1214-42
critical for EPPIN binding, we cloned and expressed six
SEMG1 truncated fragments lacking N-terminal and/or C-
terminal sequences flanking Cys239 residue, namely
SEMG174-42, SEMG174-8, SEMG132-42, SEMG119-22, SEMG110-30,
and SEMG132-8 (Figure 2B). We designed these truncations
because they correspond to SEMG1 fragments containing the
Cys239 residue generated by PSA digestion [6] and are part of
the 15-kDa SEMG1 fragment protected from PSA cleavage by
EPPIN [7]. Thus, it is likely they are naturally generated during
the semen liquefaction. Among these fragments, only
SEMG174-42 and SEMG174-8 bound to EPPIN, albeit at much
higher concentrations (1 - 7.5 µM) in comparison to the largest
fragment SEMG1214-42 (Figure 3A). We observed no saturation
when SEMG174-42 and SEMG174-8 fragments were titrated in the
presence of EPPIN under similar conditions (Figure 3A).
To confirm these results, we performed competition
experiments to investigate the capacity of SEMG1 fragments to
Figure 1.  Molecular phylogenetic analysis for EPPIN and SEMG1 within the primate lineage.  EPPIN (A) and SEMG1 (B)
trees were drawn to scale with branch lengths measured in the number of substitutions per site. GenBank accession number for
each DNA sequence used for EPPIN and SEMG1 analyses are shown in Table 6.
doi: 10.1371/journal.pone.0082014.g001
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Table 1. Test of the homogeneity of substitution patterns
between sequences for EPPIN.
Species 1 2 3 4 5 6 7 8
1 Homo sapiens - 0.000 0.005* 0.002* 0.000 0.000 0.000 0.000
2 Pan troglodytes 1.000 - 0.005* 0.000 0.000 0.000 0.000 0.000
3 Gorilla gorilla
gorilla
0.314 0.320 - 0.017* 0.000 0.000 0.000 0.000
4 Pongo abelii 0.442 1.000 0.172 - 0.000 0.015* 0.010* 0.000
5 Nomascus
leucogenys
1.000 1.000 1.000 1.000 - 0.000 0.000 0.000
6 Macaca
mulatta
1.000 1.000 1.000 0.338 1.000 - 0.000 0.000




1.000 1.000 1.000 1.000 1.000 1.000 1.000 -
MEGA molecular evolutionary genetic analysis software package (version 5.1) [36]
used a Monte Carlo test (500 replicates) to estimate the p-values [38], which are
shown above the diagonal (bold). * p-values < 0.05 were considered significant.
Estimates of the disparity index per site are shown for each sequence pair below
the diagonal (italic). There were a total of 402 positions in the final dataset.
GenBank accession number for each DNA sequence used for EPPIN and SEMG1
analyses are shown in Table 6.
doi: 10.1371/journal.pone.0082014.t001
Table 2. Test of the homogeneity of substitution patterns
between sequences for SEMG1.
Species 1 2 3 4 5 6 7 8
1 Homo sapiens - 0.000 0.051# 0.011* 0.000 0.000 0.000 0.000
2 Pan
troglodytes
1.000 - 0.075 0.011* 0.000 0.000 0.000 0.000
3 Gorilla gorilla
gorilla
0.192 0.102 - 0.192 0.141 0.019* 0.000 0.123
4 Pongo abelii 0.234 0.226 0.022 - 0.000 0.000 0.039* 0.000
5 Nomascus
leucogenys
1.000 1.000 0.024 1.000 - 0.000 0.000 0.000
6 Macaca
mulatta
1.000 1.000 0.280 1.000 1.000 - 0.000 0.000




1.000 1.000 0.174 1.000 1.000 1.000 1.000 -
MEGA molecular evolutionary genetic analysis software package (version 5.1) [36]
used a Monte Carlo test (500 replicates) to estimate the p-values [38], which are
shown above the diagonal (bold). * p-values < 0.05 were considered significant.
Estimates of the disparity index per site are shown for each sequence pair below
the diagonal (italic). There were a total of 738 positions in the final dataset. #
indicates a trend towards heterogeneity, although it was not significant. GenBank
accession number for each DNA sequence used for EPPIN and SEMG1 analyses
are shown in Table 6.
doi: 10.1371/journal.pone.0082014.t002
compete with biotinylated (bt)-SEMG1214-42 for its binding site
on EPPIN. SEMG1214-42 decreased bt-SEMG1214-42/EPPIN
interaction in a concentration-dependent manner (Figure 3B)
with a calculated IC50 value (95% confidence interval) of 8.1 nM
(6.8-9.7 nM). Both SEMG174-42 and SEMG174-8 inhibited the
binding of bt-SEMG1214-42 to EPPIN at higher concentrations in
comparison to SEMG1214-42 (Figure 3B). The calculated IC50
values were 123.7 nM (92.4-165.7 nM) and 384.7 nM
(104.2-1421 nM) for SEMG174-42 and SEMG174-8, respectively.
Curiously, SEMG132-8 competed with bt-SEMG1214-42 for binding
EPPIN at even higher concentrations (Figure 3B), with an IC50
of 5.1 µM (0.3-75.2 µM).
Next, we measured the binding of the SEMG1214-42 Cys239
point mutants to EPPIN in the AlphaScreen assay. All point
mutations negatively affected SEMG1/EPPIN binding as
demonstrated by right-shifted concentration-response curves
(Figure 3C) and consequently increased EC50 values (Table 5)
in comparison to the wild-type when SEMG1214-42 mutants were
incubated with EPPIN under similar conditions. We observed a
Table 3. Amino acid residue changes in the full-length
EPPIN sequence.
EPPIN Species
Residues 7 6 5 4 3 2 1
(position #)   ^     
8 S S S N S S S
14 I I I V V V V
17 V A A A V A A
35 T T K K K K K
43 K K K K Q Q Q
50 R R K K K K K
51 H H D D D D D
55 P P Q Q Q Q Q
78 E E E E E K E
81 N N K K K K K
89 F F Y Y Y Y Y
91 I I L L L L L
92 R R R R R R H
99 N N N N N N D
101 T T T T S T T
104 T T M M M M M
107 Y H Y Y Y Y Y
111 Q Q P Q Q Q Q
120 E E K K K K K
128 K K K K R K K
129 N N N K N N N
N-terminal WAP domain and C-terminal Kunitz domain are present within positions
1-74 and 75-133 of EPPIN.
^. indicates the divergence of the Catarrhini into the Hominoidea (species 1-5) and
Cercopithecoidea (species 6 and 7), 31.6 MYA; Changes after the split are shown
in bold/italics. Residues 101 (Serine) and 128 (Arginine) in the Gorilla sequence
represent changes unique to Gorilla. Residues 92 (Histidine) and 99 (Aspartic acid)
in the Homo sapiens sequence represent changes unique to Homo sapiens.
Species: 1, Homo sapiens; 2, Pan troglodytes; 3, Gorilla gorilla; 4, Pongo abelii; 5,
Nomascus leucogenys; 6, Macaca mulatta; 7, Papio anubis.
doi: 10.1371/journal.pone.0082014.t003
Evolution of SEMG1/EPPIN Binding on Spermatozoa
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~4-fold, ~8-fold and ~20-fold increase in the EC50 values of
SEMG1/EPPIN binding when glycine/aspartic acid, histidine or
serine/arginine residues replaced the Cys239 residue,
respectively (Table 5). Altogether, we confirmed previous
observations that the Cys239 residue within human SEMG1
primary sequence plays a critical role in the SEMG1/EPPIN
interaction. Additionally, our results indicated that sequences
within SEMG1 repeats IIIa, IIa and IIb flanking Cys239 residue
may provide interacting interfaces that significantly enhance
SEMG1/EPPIN interaction.
Effect of SEMG1 fragments and Cys239 mutants on
sperm motility
We have previously demonstrated that the recombinant
SEMG1214-42 fragment inhibited different sperm movement-
related parameters, including motility, progressive motility and
Figure 2.  Human semenogelin I (SEMG1) sequence.  A) SEMG1 primary sequence. Signal peptide is indicated by a dashed
underline. B) Schematic representation of SEMG1 containing repeats Ia, Ib, IIa, IIb, IIIa, and IIIb. Recombinant SEMG1 fragments
used in AlphaScreen assay and CASA experiments: G26-R281 (SEMG1214-42), R165-R281 (SEMG174-42), R165-Q247 (SEMG174-8),
Q207-R281 (SEMG132-42), Y220-L262 (SEMG119-22), E229-L269 (SEMG110-30), and Q207-Q247 (SEMG132-8) are shown. Cysteine
residue at position 239 is indicated by a box in (A) and a vertical arrow in (B).
doi: 10.1371/journal.pone.0082014.g002
Evolution of SEMG1/EPPIN Binding on Spermatozoa
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VSL (straight line velocity) of human ejaculate spermatozoa in
a time- and concentration-dependent manner [24]. To
determine the minimum sequence within SEMG1214-42 that
inhibits sperm motility, we incubated spermatozoa with different
recombinant SEMG1 fragments (Figure 2) and assessed by
Computer-assisted sperm analysis (CASA). Based on
observations that both sperm motility and velocity are directly
correlated to the fertilizing ability of human spermatozoa [29]
and that SEMG1 forms a gelatinous mass after ejaculation
restricting sperm movement, we developed an index (iRMI)
correlating both %motility and VSL parameters, which allowed
the normalization of each data set against its respective
control, reducing inter-assay variation due to differences in
sperm quality in different semen samples.
As expected, SEMG1214-42 at a concentration of 1.5 fmol/
sperm (2 µM) significantly decreased the normalized iRMI in
comparison to control group (Figure 4A). Surprisingly, all
SEMG1 fragments tested significantly affected sperm motility,
including those that did not bind EPPIN in the AlphaScreen
assay, as demonstrated by a decrease in the normalized iRMI
equivalent to that observed with SEMG1214-42 at the same
Table 4. Amino acid residue changes in the SEMG1
sequence (positions 165-247).
SEMG1 Species
Residues 7 6 5 4 3 2 1
(position #)   ^     
167 R R W W W W W*
169 R R H H H H H*
176 A A A T A T T
178 A A A V A V V
184 G G G G R G G*
186 T T T T K K K*
192 R R S R S S S*
193 N N S S S S S
194 Y Y Y Y H Y Y*
203 A A A A V A A*
204 N K N N N N N
206 Q Q R Q Q Q Q
208 R R G R R R R*
211 Q Q Q K K K K*
215 R R Q Q Q Q Q
225 D D E E D E E
234 L L V V L V V
239 R R C C H C C*†
242 H H Y H H H H
244 H H D G D D D
245 K K R N R K K*
^ indicates the divergence of the Catarrhini into the Hominoidea (species 1-5) and
Cercopithecoidea (species 6 and 7), 31.6 MYA; Changes after the split are shown
in bold/italics. Residues 225, 234 and 239 in the Gorilla are unique to Gorilla within
the Hominoidea. † Residue 239 is necessary for high affinity binding of SEMG1 to
human EPPIN. * Indicates BEB analysis for positively selected codons (P>95%).
Species: 1, Homo sapiens; 2, Pan troglodytes; 3, Gorilla gorilla; 4, Pongo abelii; 5,
Nomascus leucogenys; 6, Macaca mulatta; 7, Papio anubis.
doi: 10.1371/journal.pone.0082014.t004
concentration (Figure 4A). To investigate the nature of these
results, we performed concentration-response experiments in
which spermatozoa were incubated with increasing
concentrations of recombinant SEMG1214-42, SEMG174-42 and
SEMG132-8 fragments under similar conditions and the
normalized iRMI was then calculated for each concentration
point (Figure 4B). All fragments tested decreased the
normalized iRMI in a concentration-dependent fashion (Figure
4B). The calculated EC50 values (95% confidence interval)
were 1.69 µM (0.77 - 3.7 µM), 3.56 µM (1.67 - 7.63 µM), and
1.75 µM (0.50 - 6.06 µM) for SEMG1214-42, SEMG174-42 and
SEMG132-8 fragments, respectively. Based on these results, we
conclude that a region within the sequence E229-Q247 of
SEMG1 contains a domain responsible for the inhibition of
sperm motility.
CASA experiments performed with SEMG1214-42 Cys239
mutants demonstrated that only C239H-SEMG1 mutant
(His239 in the Gorilla, Table 4) significantly decreased the
normalized iRMI in a similar extent to the wild-type at a
concentration of 0.5 fmol/sperm (Figure 4C, left panel). When
the concentration was increased to 1.5 fmol/sperm all the
SEMG1 mutants, except C239G-SEMG1, significantly
decreased the normalized iRMI in comparison to control
(Figure 4C, right panel). To confirm the concentration-
dependent sperm motility inhibition of the SEMG1 Cys239
mutants, we performed concentration-response experiments
using C239H-SEMG1 and C239R-SEMG1 (Figure 4D). Both
mutants decreased the normalized iRMI in a concentration-
dependent manner (Figure 4D). The calculated EC50 values
(95% confidence interval) were 1.08 µM (0.41 - 2.84 µM) and
2.21 µM (1.14 - 4.29 µM) C239H-SEMG1 and C239R-SEMG1,
respectively.
Discussion
Although previous reports indicate that different WFDC and
SEMG genes within the WFDC locus are subject to rapid
adaptive evolutionary changes [18,19,22,30], little is known
about the molecular co-evolution of interacting proteins within
this locus. The present study investigated the hypothesis that
the interacting surface of SEMG1 and EPPIN co-evolved within
the Hominoidea time scale, as a result of adaptive pressures
applied by their roles in sperm protection and reproductive
fitness. The binding of SEMG1 to EPPIN on the surface of
spermatozoa is an important step for modulating sperm motility
and providing antimicrobial protection upon ejaculation [5,7].
Our results indicate that distinct amino acid residues of SEMG1
(Trp167, His169, Ser193, and Gln215) and EPPIN (Lys35,
Lys50, Asp51, Gln55, Lys81, Tyr89, Leu91, Met104, and
Lys120) possess a remarkable deficiency of variation among
hominoid primates. Using CodeML software in the PAML4
package [31] our analysis revealed that SEMG1 codons within
the fragment that binds to EPPIN underwent positive selection,
confirming that there has been selective pressure on SEMG1’s
EPPIN binding domain. We confirmed that SEMG1’s Cys239
residue within the SEMG1/EPPIN interacting interface is under
positive selection. Although other factors such as premature
stop codons and gene deletions or homogenizations may have
Evolution of SEMG1/EPPIN Binding on Spermatozoa
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accounted for positive selection during the evolutionary history
of SEMG1 [18], in humans Cys239’s role in increasing the
binding affinity of SEMG1 for EPPIN results in a functional gain
in the modulation of sperm motility in the semen coagulum at
lower concentrations. In fact, our binding and functional studies
in vitro demonstrate that SEMG1 truncations flanking the
Cys239 residue or point mutations at this position decrease the
binding of SEMG1 to EPPIN and reduce its sperm motility
inhibitory effect in a concentration-dependent fashion. Although
none of EPPIN’s codons underwent positive selection, which
may indicate the conserved stability of EPPIN itself, there were
two distinct changes in humans compared to all other
Hominoidea; residues His92 and Asp99. Altogether, our results
provide unique insights into the co-evolution of binding partners
on the surface of ejaculate spermatozoa.
Previously, we demonstrated that blocking human SEMG1’s
unique cysteine residue (Cys239) either by reduction and
carboxymethylation or by a point mutation to a glycine blocked
its capacity to bind EPPIN and to inhibit sperm motility [24,25],
indicating that this residue played a major role in SEMG1
Figure 3.  Binding of recombinant SEMG1 fragments to EPPIN in the AlphaScreen assay.  A) Concentration-response curve
for SEMG1214-42, SEMG174-42, SEMG174-8, and SEMG132-8 in the presence of a constant concentration of EPPIN. B) Displacement of
bt-SEMG1214-42 from its binding site on EPPIN by SEMG1 constructs. Specific signal for each data point was normalized as
percentage of specific signal in the absence of SEMG1 competitors. Data are expressed as mean ± SD from two independent
experiments, each performed in four replicates. C) Concentration-response curve for SEMG1214-42 (wild-type) and Cys239 mutants
(C239G, C239D, C239H, C239R, C239S) in the presence of a constant concentration of EPPIN. Data points in (A) and (C)
represent mean ± SD of specific signal from a representative experiment of (A) four (SEMG1214-42 and SEMG174-42) and two
(SEMG174-8) experiments; and (C) three experiments, each performed in four replicates. cps = counts per second.
doi: 10.1371/journal.pone.0082014.g003
Evolution of SEMG1/EPPIN Binding on Spermatozoa
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biological activities. In an effort to further characterize SEMG1
sequences responsible for binding EPPIN and inhibiting sperm
motility we tested the capacity of multiple recombinant SEMG1
fragments and Cys239 mutants to bind EPPIN and to inhibit
human sperm motility. It is noteworthy that all smaller SEMG1
constructs tested correspond to SEMG1 fragments generated
by PSA digestion upon ejaculation [6], making them
endogenous to the liquefied semen. Our results demonstrated
that the whole G26-R281 sequence in SEMG1214-42 was
necessary for optimal SEMG1/EPPIN interaction, since this
construct had the lowest EC50 and IC50 values among the
SEMG1 fragments tested in concentration-response and
competition experiments, respectively.
Interestingly, micromolar concentrations of the SEMG132-8
construct were able to inhibit the interaction between EPPIN
and bt-SEMG1 in competition experiments, although it did not
directly bind to EPPIN in concentration-response experiments.
Besides the reduced capacity of this fragment to bind EPPIN at
higher concentrations, it is possible that aggregation between
SEMG132-8 and bt-SEMG1 may have masked the EPPIN
binding site in bt-SEMG1 in our assay conditions, thereby
leading to a concentration-dependent reduction in the signal. In
addition, we cannot discard the possibility that the N-terminal
6X His tag present in the recombinant proteins may disturb the
binding capacity of the smallest SEMG1 constructs to EPPIN
due to steric/folding issues, which could lead to the absence of
interaction in the direct binding assay at the concentrations
tested.
Despite the importance of the Cys239 residue to SEMG1
biological activity, our phylogenetic analysis demonstrated that
this residue is not highly conserved among primates; positively
charged residues histidine or arginine replace the cysteine in
SEMG1 from Gorilla gorilla and Cercopithecoidea species
Macaca mulatta and Papio anubis, respectively. Based on
these observations, we decided to further investigate the
physiological significance of this change to SEMG1 function by
mutating Cys239 (cysteine = polar) residue in human
SEMG1214-42 to histidine (basic), arginine (hydrophilic/basic), as
well as glycine (hydrophobic), aspartic acid (negatively
charged) and serine (hydrophilic) residues. Our results
demonstrated that all SEMG1 mutants required much higher
concentrations than the wild-type to bind to EPPIN, as
indicated by higher EC50 values in the concentration-response
experiments. An interesting observation was the fact that the
Table 5. EC50 values for the binding of each indicated
SEMG1 construct to EPPIN by AlphaScreen assay.
SEMG1 isoform EC50 (95% conf. interval)
SEMG1214-42 23.1 nM (21.3 - 25.0 nM)
C239G-SEMG1214-42 83.3 nM (76.1 - 91.3 nM)
C239D-SEMG1214-42 96.1 nM (91.5 - 101.0 nM)
C239H-SEMG1214-42 167.0 nM (160.0 - 174.0 nM)
C239R-SEMG1214-42 461.0 nM (97.4 - 2180 nM)
C239S-SEMG1214-42 564.4 nM (8.3 - 3836 nM)
EC50 calculations were performed with data showed in Figure 3C.
doi: 10.1371/journal.pone.0082014.t005
C239H-SEMG1 mutant possessed a ~4-fold higher EPPIN
binding activity than the C239R-SEMG1 mutant based on EC50
values, suggesting that the size of the side-chain of the residue
at this position may hamper SEMG1/EPPIN interaction by
inducing steric effects. Taken together, our experimental data
support the observation that human SEMG1’s Cys239 residue
is a hot site subject to positive selection, probably because of
its major role in increasing the affinity of SEMG1 for EPPIN on
the sperm surface, which can result in an effective gain of
function by allowing an effective binding at lower
concentrations. Our results further indicate that the sequence
G26-E164, which is part of the repeat IIIa, provide a docking
surface that is critical for the SEMG1-EPPIN interaction in
addition to the Cys239 residue, leading us to hypothesize that
SEMG1 has multiple EPPIN interaction sites within repeats IIIa
and IIb of the molecule. This hypothesis is further supported by
the observation that residues Cys102, Tyr107, and Phe117 in
EPPIN’s SEMG1 binding pocket are independently important
for SEMG1 interaction [23].
We and others have demonstrated by computer analyses of
sperm motility that both native and recombinant SEMG1
decreased motility parameters, such as percentage motility and
straight line velocity of human ejaculate spermatozoa in a
concentration- and time-dependent fashion [15,16,24,32].
Recent studies from our laboratory have begun to unravel the
basic mechanisms underlying the SEMG1-mediated inhibition
of sperm motility triggered by its interaction with EPPIN on the
sperm surface, namely the decrease of intracellular pH leading
to a drop in intracellular calcium levels by blocking extracellular
calcium uptake [15,16]. These observations demonstrated that
the effects of SEMG1 on sperm motility are finely regulated by
a cascade of molecular events rather than by simply trapping
spermatozoa by physical constraint in the semen coagulum. In
our study, an intriguing observation was the fact that all smaller
SEMG1 constructs tested inhibited sperm motility to a similar
extent as SEMG1214-42, including those that did not bind EPPIN
in the AlphaScreen assay. Differences in the nature of these
assays may explain our results: while the AlphaScreen assay
measures the interaction between EPPIN and SEMG1
molecules in vitro with high sensitivity (nanomolar range),
CASA analysis reflects a biological effect in a live cell, namely
loss of sperm motility, which is dependent on a cascade of
molecular events initiated by the same interaction, such as
changes in intracellular pH and extracellular calcium uptake
[15,16]. It is possible that the saturation of EPPIN binding sites
with SEMG1 on the surface of spermatozoa, which would
induce the formation of large macromolecular complexes, may
be required for their immobilization.
It has been widely recognized that genes with roles in innate
immunity and reproduction are evolving rapidly by positive
Darwinian selection, particularly those associated with the male
reproductive tract [33-35]. Consistently, the evolution of
different sperm- and semen-associated proteins, such as
SEMG and WFDC genes in the primate lineage, is rapid and
driven by positive selective forces, especially in relation to
sexual function and sperm competition [19]. In fact, the nearly
significant heterogeneity between Gorilla and Homo sapiens
SEMG1 further suggests an ongoing divergent evolutionary
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Figure 4.  Effect of recombinant SEMG1 constructs on human sperm motility.  Spermatozoa were incubated with the same
concentration of recombinant SEMG1 fragments (A) or Cys239 mutants (C) and assessed by CASA. Concentration-response
curves for spermatozoa incubated in the presence of increasing concentrations of SEMG1214-42, SEMG174-42, and SEMG132-8
fragments (B) or C239H-SEMG1214-42 and C239R-SEMG1214-42 (D) were obtained. Results are presented as normalized iRMI
(%motility*VSL of sample/%motility*VSL of control). Control untreated experiments were performed with buffer only. Data are
representative of mean ± SD of independent experiments performed with ejaculate spermatozoa from six (A) or three (B, C and D)
donors. *p < 0.05, ** p < 0.01, and *** p < 0.001 when compared to control group (ANOVA followed by Bonferroni test).
doi: 10.1371/journal.pone.0082014.g004
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trend after speciation. Our results suggest that the adaptive
molecular coevolution of the interacting surface between
SEMG1 and EPPIN may have rapidly changed their
biochemical properties resulting in an increase in their binding
affinity and a gain of function for both proteins at the interface
of innate immunity and reproduction.
Materials and Methods
Phylogenetic analysis
We aligned nucleotides sequences of EPPIN and SEMG1
from Homo sapiens, Pan troglodytes, Gorilla gorilla gorilla,
Pongo abelii, Nomascus leucogenys, Macaca mulatta, Papio
anubis, and Saimiri boliviensis boliviensis (GenBank accession
numbers in Table 6) with ClustalW. We used MEGA5
molecular evolutionary genetic analysis software package
(version 5.1) [36] to obtain phylogenetic trees using the
Maximum Likelihood method based on the Tamura-Nei model
[37] and to perform the test of homogeneity of substitution
patterns between sequences for EPPIN and SEMG1 using the
neighbor-joining method [38]. Codon positions included were
1st+2nd+3rd. All positions containing gaps and missing data
were eliminated. For technical details of these tests, please
refer to their original descriptions [36-38]. We chose the
phylogenetic trees with the highest log likelihood (EPPIN)
-926.2396 or (SEMG1) -2108.0861 and used them for further
analysis. We investigated evidence of positive selection codon-
by-codon in the primate phylogenetic tree of EPPIN and
SEMG1 using the CodeML software in the PAML 4 package
[27,31]. In this case, we compared the likelihood of a nearly-
neutral model M1a with that of a selection model M2a. Next,
we compared the likelihood of a neutral model M7 with that of a
selection model M8. In both cases we used a Likelihood Ratio
Test (LRT) to determine if the selection model was a better fit
to the data than the neutral model by comparing the
(-2[Log(neutral) – Log(positive)]) value between the two models
with the χ2-distribution [18,27]. When the calculations
suggested positive selection, we used the BEB method to
calculate the probability that each codon experienced positive
selection under models M2a and M8 [27].
Table 6. List of species and sequences used in the
phylogenetic analysis of EPPIN and SEMG1.
 GenBank Accession Number
Species EPPIN SEMG1
Homo sapiens NM_020398.3 NM_003007.3
Pan troglodytes XM_003316966.1 NM_001110538.1
Gorilla gorilla gorilla XM_004062257.1 XM_004062223.1
Pongo abelii XM_002830353.1 XM_002830350.1
Nomascus leucogenys XM_003253642.1 gi|328833490:8997382-9005052
Macaca mulatta NM_001032841.1 XM_002798120.1





Production and Expression of Recombinant Proteins
Human recombinant SEMG1 (SEMG1214-42, wild-type,
residues G26-R281, Figure 2) and EPPIN (residues P22-P133)
were previously cloned into pET100/D-TOPO vector
(Invitrogen, Carlsbad, CA) [23]. Additionally, C-terminal and N-
terminal truncated fragments flanking the residue Cys239 from
the SEMG1 primary sequence, corresponding to residues
R165-R281 (SEMG174-42), R165-Q247 (SEMG174-8), Q207-
R281 (SEMG132-42), Y220-L262 (SEMG119-22), E229-L269
(SEMG110-30), and Q207-Q247 (SEMG132-8) (Figure 2B) were
produced and cloned into the same vector. All constructs were
verified by DNA sequencing. Recombinant proteins were
expressed either in BL21 StarTM (DE3) One Shot® E. coli
(Invitrogen; SEMG1 constructs) or E. coli Rosetta-Gami 2TM
(DE3) (Novagen, Madison, WI; EPPIN construct) and purified
under denaturing conditions using nickel-nitrilotriacetic acid
agarose (Ni-NTA) beads (Qiagen, Valencia, CA) as described
previously [23].
Removal of N-terminal 6X His-tag from recombinant EPPIN
was performed using recombinant enterokinase cleavage/
capture kit (Novagen), according to the manufacturer’s
instructions. For removal of undigested 6X His-tag-EPPIN, the
cleavage reaction was incubated with Ni-NTA beads at room
temperature for 30 min with gentle mixing and tag-free EPPIN
was then eluted in PBS buffer containing 1 M urea.
Recombinant SEMG1214-42 was biotinylated as described
previously [23].
In Vitro Site-Directed Mutagenesis
Site-directed mutagenesis of wild-type SEMG1214-42 of
residue Cys239 to glycine (C239G-SEMG1), aspartic acid
(C239D-SEMG1), histidine (C239H-SEMG1), serine (C239S-
SEMG1), or arginine (C239R-SEMG1) was performed using
the Gene Tailor site-directed mutagenesis system (Invitrogen),
according to the manufacturer’s instructions. Mutagenesis
products were transformed into DH5a-T1R E. coli and positive
clones selected, followed by DNA sequencing to confirm the
mutation. Recombinant SEMG1 mutants were expressed and
purified as described above.
AlphaScreen® Assay
The AlphaScreen® assay was carried as previously
described [23], with the following modifications. Briefly,
recombinant EPPIN was pre-incubated with anti-EPPIN Q20E
antibody and Protein A acceptor beads for 30 minutes. In
parallel, increasing concentrations of each recombinant
SEMG1 construct was incubated with Ni-NTA-chelate donor
beads under the same conditions. Equal volumes of each
EPPIN/Q20E/Protein A acceptor beads and SEMG1/Ni-NTA-
chelate donor beads were pipetted into in white opaque 384-
well microplates (OptiPlate-384; PerkinElmer, Waltham, MA) in
a final volume of 30 µl. Plates were covered with top seal and
transferred to a Synergy 2 Multiplatform automated plate
reader (Biotek, Winooski, VT). After shaking for 2 min, plates
were read every 2 h during 16 h: excitation using a 680/30
filter, emission using a 570/100 filter and data acquired using
Gen5 software (Biotek). A total of 9 time points were generated
during each experiment. Each set of samples was pipetted in 4
Evolution of SEMG1/EPPIN Binding on Spermatozoa
PLOS ONE | www.plosone.org 10 December 2013 | Volume 8 | Issue 12 | e82014
replicates. The final concentration of assay components was
29 nM EPPIN, 2 nM Q20E antibody, 0.04-7.5 µM SEMG1, and
10 µg/ml beads. Negative controls were performed under the
same conditions in the absence of EPPIN or SEMG1 and in the
presence of beads only. A specific signal for each time point
was calculated by subtracting the background signal (obtained
in the absence of SEMG1) from its respective total signal.
EC50 values for the binding of EPPIN to each SEMG1
construct were calculated by non-linear regression curve fitting
using the specific signal obtained after 16 h of incubation.
Competition experiments using AlphaScreen assay platform
were performed as previously described [23]. Briefly, EPPIN
(10 nM) and biotinylated (bt-)SEMG1214-42 (1 nM) were
incubated in the presence of increasing concentrations of
SEMG1214-42, SEMG174-42, SEMG174-8, or SEMG132-8 (10 pM – 8
µM) in a 30 µl reaction. The bead concentration was 15 µg/ml.
The specific signal for each competitor concentration point was
calculated as described above and the IC50 values were
calculated by nonlinear regression curve fitting.
Preparation of spermatozoa and analysis of sperm
motility
Human semen samples were obtained from the Department
of Obstetrics and Gynecology, University of North Carolina
Memorial Hospital, Chapel Hill, NC. This study was approved
by the Committee on the Protection of the Rights of Human
Subjects at the University of North Carolina, School of
Medicine Chapel Hill, NC. The Institutional Review Board
determined that this study did not constitute human subjects
research as defined under U.S. federal regulations [45 CFR
46.102 (d or f) and 21 CFR 56.102(c)(e)(l)] and the need for
informed consent was waived. All samples were de-identified
before further processing. Semen samples were allowed to
liquefy for 30 min and subjected to standard semen analysis to
determine acceptability and either used fresh or stored in liquid
nitrogen. An isolate gradient (Irving Scientific, Irving, CA, cat.
#99264) was used to prepare spermatozoa for further analysis
[15].
Aliquots of sperm suspension (1500 cells/µl) were incubated
with increasing concentrations of each SEMG1 construct (0 -
35.6 µM; diluted in modified M16 medium no phenol red
(Millipore, Billerica, MA, cat. #MR/010/D) supplemented with 50
µM ZnCl2 in 12- X 75-mm glass tubes at 37°C and 5% CO2 for
1-2 h. We repeated each experiment with spermatozoa from at
least three different ejaculates and evaluated at least 100 cells
(range 100-1000 cells) from each data point.
The analysis of sperm motility after incubation with SEMG1
constructs was carried out using computer-assisted sperm
analysis (CASA; Ceros version 14.8 software, Hamilton-
Thorne), as previously described [24]. In each case, the
percentage sperm motility (%motility) and straight-line velocity
(VSL; the average velocity measured in a straight line from the
beginning to the end of track in µm/sec) were used to calculate
the index of relative motility inhibition (iRMI) as: %motility*VSL.
Normalized iRMI was calculated by dividing the iRMI of each
experimental condition by its respective control (absence of
SEMG1).
Statistical analysis
Results from AlphaScreen assays and CASA experiments
were expressed as mean ± standard deviation (SD) or
standard error of the mean (SEM) from the indicated number of
independent experiments. For statistical significance, one-way
analysis of variance (ANOVA) followed by the Bonferroni test
was performed using GraphPad Prism 5.0 software. p < 0.05
was considered statistically significant.
Supporting Information
Table S1.  Likelihood ratio test between different
evolutionary models for EPPIN (A) and SEMG1 (B).
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Table S2.  Log-likelihood values and parameter estimates
for SEMG1.
(PDF)
Figure S1.  Characterization of the interaction between
EPPIN and his-SEMG1 (SEMG1214-42 fragment) in the
AlphaScreen Assay. A) Time-course experiment showing the
interaction between SEMG1214-42 and EPPIN. Background
signal was detected when beads were incubated in the
absence of SEMG1214-42. B) Concentration-response curve for
SEMG1214-42 in the presence of a constant concentration of
EPPIN. A reduction in the signal (hook effect, arrow) was
observed with his-SEMG1 concentrations higher than 300 nM.
Negative control was performed in the absence of EPPIN.
Specific signal for each data point was determined by
subtracting the background signal from total signal. Data points
represent mean ± SD of specific signal from a representative
experiment of four experiments, each performed in four
replicates. cps = counts per second.
(PDF)
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